Conduit Pharma stockholders approve reverse stock split up to 1-for-250 at special meeting

CDT Equity Inc.

Proposal passed with 5,065,868 votes for, 496,473 against, 1,438 abstentions.
Board may implement split at ratios from 1-for-2 to 1-for-100, aggregate not exceeding 1-for-250.
The reverse stock split amendments to the certificate of incorporation have been authorized.
Company's common stock trades under CDT on Nasdaq; warrants trade under CDTTW.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.